MicrobiologybioRxiv
Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
K. Steuten, H. Kim, J. C. Widen…·M. Bogyo
This study evaluates compounds targeting SARS-CoV-2 proteases Mpro and PLpro, finding limited efficacy for Mpro due to off-target inhibition of host cathepsins and no viable hits for PLpro.
DOI 10.1021/acsinfecdis.0c00815